Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05435547 · ClinicalTrials.gov registry record · Phase 4
Preoperative Corticosteroids in Autoimmune Thyroid Disease
A Phase 4 study of Graves Disease and Hashimoto Disease, sponsored by Indiana University.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 76
- Enrollment target
- 3
- Study locations
NCT05435547 is a Phase 4 study of Graves Disease and Hashimoto Disease that is actively recruiting participants, run by Indiana University. The registered enrollment target is 76 participants, below the 303-participant average among 11 other Graves Disease trials with a reported enrollment target (75% lower). The trial reports 3 study locations across 1 state.
The verdict
NCT05435547, a Phase 4 study of Graves Disease and Hashimoto Disease, is actively recruiting participants, sponsored by Indiana University.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 76 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study proposes to randomize patients about to undergo surgery for their autoimmune, inflammatory thyroid disease, and determine if a short course of corticosteroids decreases the inflammation of the gland and makes surgery less difficult.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Dexamethasone
Study Locations (3)
Indiana
- IU Health North Hospital - Indianapolis
- IU Health Methodist Hospital - Indianapolis
- IU Health University Hospital - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2023-06-16 |
| Est. Completion | 2026-12-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05435547
The ClinicalTrials.gov registry entry for NCT05435547 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 303-participant average among 11 other Graves Disease trials with a reported enrollment target (75% lower). The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Graves Disease appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT05435547 reports 3 study locations spanning 1 distinct geographic area - top geographies include Indiana.
Frequently Asked Questions
What is clinical trial NCT05435547 about?
NCT05435547 is a clinical study titled "Preoperative Corticosteroids in Autoimmune Thyroid Disease". This study proposes to randomize patients about to undergo surgery for their autoimmune, inflammatory thyroid disease, and determine if a short course of corticosteroids decreases the inflammation of the gland and makes surgery less difficult.
What is the current status of trial NCT05435547?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 76 participants. The study started on 2023-06-16. Estimated completion is 2026-12-30.
What conditions does trial NCT05435547 study?
This clinical trial studies the following conditions: Graves Disease, Hashimoto Disease.
What interventions are being tested in trial NCT05435547?
The interventions under investigation include: Placebo (DRUG), Dexamethasone (DRUG).
Who is sponsoring clinical trial NCT05435547?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05435547 being conducted?
This trial has 3 study locations across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Graves Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
NEXUS Study: A Study to Test Single and Multiple Doses of MER511 Given to Adults With Graves' Disease
RECRUITING · Phase 1
-
Impact of Vitamin D Therapy on Thyroid Function and Antibody Levels in Pediatric Graves' Disease
RECRUITING · Phase 2
-
Study of BHV-1300 in Graves' Disease
RECRUITING · Phase 1
-
Personalized Treatment in Thyroid Disorders
RECRUITING · NA
-
The Effect of Teprotumumab on Thyroid Eye Disease and Thyroid Dysfunction
RECRUITING
-
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.